Studying CBD
No Result
View All Result
  • Home
  • CBD
  • About CBD
  • What is CBD
  • Home
  • CBD
  • About CBD
  • What is CBD
No Result
View All Result
Studying CBD
No Result
View All Result
Home About CBD

Why Shares of Charlotte’s Web Holding Bounced 10.6% Higher Today

Peter F. by Peter F.
October 3, 2019
in About CBD
39 0
0
Why Shares of Charlotte’s Web Holding Bounced 10.6% Higher Today
32
SHARES
358
VIEWS
Share on TwitterShare on Facebook

[ad_1]

What happened

Shares of Charlotte’s Web Holdings (OTC:CWBHF) closed 10.6% higher on Wednesday. The nice bounce came after the stock sank 10.9% on Tuesday. Yet again, Charlotte’s Web didn’t have any news to cause a major swing. Instead, today’s move was apparently just another example of the sometimes inexplicable volatility associated with hemp- and cannabis-related stocks.

So what

When a stock posts a big gain or a big loss as Charlotte’s Web has done for two consecutive days for no apparent reasons, the best thing for investors to do is…nothing. Instead, stay focused on the underlying prospects for the company.

CBD oil bottle next to hemp

Image source: Getty Images.

Charlotte’s Web is betting on major growth in the U.S. hemp CBD market. The company has significantly boosted its production capacity. It’s increased staffing as well. While opinions vary as to how big the hemp CBD market might be, nearly everyone agrees that there’s plenty of room for growth.

Perhaps the most noteworthy sign that its prospects are quite good is the impressive growth in the number of retail stores that carry the company’s CBD products. So far this year, its retail distribution network has more than doubled to over 8,000 stores, including major retail chains such as Kroger and The Vitamin Shoppe.

Now what

Revenue should continue to soar throughout the rest of 2019 and into next year. The question, though, is just how much growth the company will be able to achieve. Its full-year guidance calls for revenue between $120 million and $170 million — a really wide range.

RELATED  This Is Why Federal Agencies Are Warning Employees About CBD

The company couldn’t be more specific because of uncertainty about what actions the Food and Drug Administration will take regarding regulating CBD products. With the process still underway, the stock could continue to be highly volatile for a while.



[ad_2]

Source link

Tweet8Share13Share3Share
Peter F.

Peter F.

We study the effects of cannabidiol (CBD), a non-psychoactive component of cannabis that does not produce the high associated with smoking or using it."There is a lot of debate on the health effects of marijuana and the use of cannabinoids, which are a group of compounds found in marijuana that have anti-inflammatory, pain-relieving, anti-nausea and anti-emetic properties. However, there is a lack of solid scientific evidence to guide us in the application of cannabis therapeutics."

No Result
View All Result
  • Privacy Policy
  • Contact
  • About us

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.. For more information contact Info@sdmediagrp.comContinuePrivacy policy